nodes	percent_of_prediction	percent_of_DWPC	metapath
Lurasidone—CYP3A4—Thiotepa—sarcoma	0.0596	0.458	CbGbCtD
Lurasidone—CYP3A4—Mitoxantrone—sarcoma	0.0256	0.197	CbGbCtD
Lurasidone—HTR7—pulmonary artery—sarcoma	0.0236	0.164	CbGeAlD
Lurasidone—CYP3A4—Vincristine—sarcoma	0.0176	0.136	CbGbCtD
Lurasidone—CYP3A4—Etoposide—sarcoma	0.0162	0.124	CbGbCtD
Lurasidone—HTR2A—pulmonary artery—sarcoma	0.0147	0.102	CbGeAlD
Lurasidone—CYP3A4—Doxorubicin—sarcoma	0.011	0.0847	CbGbCtD
Lurasidone—HTR2A—hindlimb—sarcoma	0.0089	0.0617	CbGeAlD
Lurasidone—HTR2A—appendage—sarcoma	0.00764	0.053	CbGeAlD
Lurasidone—HTR7—endothelium—sarcoma	0.00739	0.0513	CbGeAlD
Lurasidone—HTR2A—endothelium—sarcoma	0.00461	0.032	CbGeAlD
Lurasidone—ADRA2C—myometrium—sarcoma	0.00389	0.0269	CbGeAlD
Lurasidone—HTR1A—hematopoietic system—sarcoma	0.0038	0.0263	CbGeAlD
Lurasidone—HTR7—hematopoietic system—sarcoma	0.00363	0.0252	CbGeAlD
Lurasidone—ADRA2C—seminal vesicle—sarcoma	0.00351	0.0243	CbGeAlD
Lurasidone—HTR7—connective tissue—sarcoma	0.0035	0.0242	CbGeAlD
Lurasidone—HTR7—smooth muscle tissue—sarcoma	0.0032	0.0222	CbGeAlD
Lurasidone—ADRA2A—myometrium—sarcoma	0.0031	0.0215	CbGeAlD
Lurasidone—ADRA2A—seminal vesicle—sarcoma	0.0028	0.0194	CbGeAlD
Lurasidone—ADRA2A—hematopoietic system—sarcoma	0.00266	0.0185	CbGeAlD
Lurasidone—ADRA2A—connective tissue—sarcoma	0.00256	0.0178	CbGeAlD
Lurasidone—HTR2A—embryo—sarcoma	0.00254	0.0176	CbGeAlD
Lurasidone—ADRA2C—cardiac atrium—sarcoma	0.00253	0.0176	CbGeAlD
Lurasidone—ADRA2C—uterus—sarcoma	0.00252	0.0175	CbGeAlD
Lurasidone—HTR7—tendon—sarcoma	0.0024	0.0167	CbGeAlD
Lurasidone—HTR2A—hematopoietic system—sarcoma	0.00226	0.0157	CbGeAlD
Lurasidone—ADRA2C—tendon—sarcoma	0.00221	0.0153	CbGeAlD
Lurasidone—HTR2A—connective tissue—sarcoma	0.00218	0.0151	CbGeAlD
Lurasidone—CYP3A4—hematopoietic system—sarcoma	0.0021	0.0145	CbGeAlD
Lurasidone—ADRA2A—cardiac atrium—sarcoma	0.00202	0.014	CbGeAlD
Lurasidone—ADRA2A—uterus—sarcoma	0.00201	0.0139	CbGeAlD
Lurasidone—HTR2A—smooth muscle tissue—sarcoma	0.00199	0.0138	CbGeAlD
Lurasidone—HTR7—testis—sarcoma	0.00199	0.0138	CbGeAlD
Lurasidone—Infection—Vincristine—sarcoma	0.00189	0.00261	CcSEcCtD
Lurasidone—Dyspepsia—Thiotepa—sarcoma	0.00189	0.00261	CcSEcCtD
Lurasidone—Hot flush—Epirubicin—sarcoma	0.00188	0.0026	CcSEcCtD
Lurasidone—DRD2—testis—sarcoma	0.00188	0.013	CbGeAlD
Lurasidone—HTR7—liver—sarcoma	0.00188	0.013	CbGeAlD
Lurasidone—Increased appetite—Epirubicin—sarcoma	0.00187	0.00258	CcSEcCtD
Lurasidone—Diabetes mellitus—Doxorubicin—sarcoma	0.00187	0.00258	CcSEcCtD
Lurasidone—Nervous system disorder—Vincristine—sarcoma	0.00187	0.00258	CcSEcCtD
Lurasidone—Decreased appetite—Thiotepa—sarcoma	0.00187	0.00258	CcSEcCtD
Lurasidone—Menopausal symptoms—Epirubicin—sarcoma	0.00187	0.00257	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Thiotepa—sarcoma	0.00186	0.00256	CcSEcCtD
Lurasidone—Decreased appetite—Dactinomycin—sarcoma	0.00186	0.00256	CcSEcCtD
Lurasidone—Fatigue—Thiotepa—sarcoma	0.00185	0.00255	CcSEcCtD
Lurasidone—Infection—Mitoxantrone—sarcoma	0.00184	0.00254	CcSEcCtD
Lurasidone—Hyperhidrosis—Vincristine—sarcoma	0.00184	0.00254	CcSEcCtD
Lurasidone—Fatigue—Dactinomycin—sarcoma	0.00184	0.00254	CcSEcCtD
Lurasidone—Back pain—Etoposide—sarcoma	0.00183	0.00252	CcSEcCtD
Lurasidone—ADRA2C—testis—sarcoma	0.00183	0.0127	CbGeAlD
Lurasidone—Shock—Mitoxantrone—sarcoma	0.00183	0.00252	CcSEcCtD
Lurasidone—Muscle spasms—Etoposide—sarcoma	0.00182	0.00251	CcSEcCtD
Lurasidone—Tachycardia—Mitoxantrone—sarcoma	0.00181	0.0025	CcSEcCtD
Lurasidone—Skin disorder—Mitoxantrone—sarcoma	0.0018	0.00249	CcSEcCtD
Lurasidone—Lethargy—Epirubicin—sarcoma	0.0018	0.00248	CcSEcCtD
Lurasidone—Cerebrovascular accident—Epirubicin—sarcoma	0.0018	0.00248	CcSEcCtD
Lurasidone—Hyperhidrosis—Mitoxantrone—sarcoma	0.0018	0.00247	CcSEcCtD
Lurasidone—Hypotension—Vincristine—sarcoma	0.00178	0.00246	CcSEcCtD
Lurasidone—ADRA2A—tendon—sarcoma	0.00176	0.0122	CbGeAlD
Lurasidone—Osteoarthritis—Epirubicin—sarcoma	0.00176	0.00243	CcSEcCtD
Lurasidone—Gastrointestinal pain—Thiotepa—sarcoma	0.00176	0.00242	CcSEcCtD
Lurasidone—Anaemia—Etoposide—sarcoma	0.00175	0.00241	CcSEcCtD
Lurasidone—Gastrointestinal pain—Dactinomycin—sarcoma	0.00175	0.00241	CcSEcCtD
Lurasidone—Hot flush—Doxorubicin—sarcoma	0.00174	0.0024	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Vincristine—sarcoma	0.00174	0.00239	CcSEcCtD
Lurasidone—Hypotension—Mitoxantrone—sarcoma	0.00174	0.00239	CcSEcCtD
Lurasidone—Increased appetite—Doxorubicin—sarcoma	0.00173	0.00239	CcSEcCtD
Lurasidone—ADRA2C—liver—sarcoma	0.00173	0.012	CbGeAlD
Lurasidone—Menopausal symptoms—Doxorubicin—sarcoma	0.00173	0.00238	CcSEcCtD
Lurasidone—Insomnia—Vincristine—sarcoma	0.00172	0.00238	CcSEcCtD
Lurasidone—Malaise—Etoposide—sarcoma	0.00171	0.00235	CcSEcCtD
Lurasidone—Vertigo—Etoposide—sarcoma	0.0017	0.00234	CcSEcCtD
Lurasidone—Abdominal pain—Thiotepa—sarcoma	0.0017	0.00234	CcSEcCtD
Lurasidone—Leukopenia—Etoposide—sarcoma	0.00169	0.00233	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00169	0.00233	CcSEcCtD
Lurasidone—Abdominal pain—Dactinomycin—sarcoma	0.00169	0.00233	CcSEcCtD
Lurasidone—Loss of consciousness—Etoposide—sarcoma	0.00166	0.00229	CcSEcCtD
Lurasidone—Cerebrovascular accident—Doxorubicin—sarcoma	0.00166	0.00229	CcSEcCtD
Lurasidone—Lethargy—Doxorubicin—sarcoma	0.00166	0.00229	CcSEcCtD
Lurasidone—Decreased appetite—Vincristine—sarcoma	0.00166	0.00228	CcSEcCtD
Lurasidone—Dyspnoea—Mitoxantrone—sarcoma	0.00166	0.00228	CcSEcCtD
Lurasidone—Somnolence—Mitoxantrone—sarcoma	0.00165	0.00228	CcSEcCtD
Lurasidone—Blood creatinine increased—Epirubicin—sarcoma	0.00165	0.00227	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Vincristine—sarcoma	0.00165	0.00227	CcSEcCtD
Lurasidone—Fatigue—Vincristine—sarcoma	0.00164	0.00227	CcSEcCtD
Lurasidone—Convulsion—Etoposide—sarcoma	0.00164	0.00226	CcSEcCtD
Lurasidone—Dyspepsia—Mitoxantrone—sarcoma	0.00163	0.00225	CcSEcCtD
Lurasidone—Hypertension—Etoposide—sarcoma	0.00163	0.00225	CcSEcCtD
Lurasidone—Osteoarthritis—Doxorubicin—sarcoma	0.00163	0.00225	CcSEcCtD
Lurasidone—Decreased appetite—Mitoxantrone—sarcoma	0.00161	0.00222	CcSEcCtD
Lurasidone—Orthostatic hypotension—Epirubicin—sarcoma	0.00161	0.00222	CcSEcCtD
Lurasidone—Abdominal pain upper—Epirubicin—sarcoma	0.00161	0.00222	CcSEcCtD
Lurasidone—Fatigue—Mitoxantrone—sarcoma	0.0016	0.00221	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.0016	0.00221	CcSEcCtD
Lurasidone—Breast disorder—Epirubicin—sarcoma	0.00159	0.00219	CcSEcCtD
Lurasidone—Nasopharyngitis—Epirubicin—sarcoma	0.00158	0.00217	CcSEcCtD
Lurasidone—Gastrointestinal pain—Vincristine—sarcoma	0.00156	0.00215	CcSEcCtD
Lurasidone—Gastritis—Epirubicin—sarcoma	0.00156	0.00215	CcSEcCtD
Lurasidone—Alanine aminotransferase increased—Epirubicin—sarcoma	0.00155	0.00214	CcSEcCtD
Lurasidone—Asthenia—Thiotepa—sarcoma	0.00154	0.00213	CcSEcCtD
Lurasidone—Infection—Etoposide—sarcoma	0.00153	0.00211	CcSEcCtD
Lurasidone—Asthenia—Dactinomycin—sarcoma	0.00153	0.00211	CcSEcCtD
Lurasidone—Blood creatinine increased—Doxorubicin—sarcoma	0.00153	0.0021	CcSEcCtD
Lurasidone—Influenza—Epirubicin—sarcoma	0.00152	0.0021	CcSEcCtD
Lurasidone—Dysphagia—Epirubicin—sarcoma	0.00152	0.0021	CcSEcCtD
Lurasidone—Pruritus—Thiotepa—sarcoma	0.00152	0.0021	CcSEcCtD
Lurasidone—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00152	0.00209	CcSEcCtD
Lurasidone—Tachycardia—Etoposide—sarcoma	0.00151	0.00208	CcSEcCtD
Lurasidone—Eosinophilia—Epirubicin—sarcoma	0.00151	0.00208	CcSEcCtD
Lurasidone—Abdominal pain—Vincristine—sarcoma	0.00151	0.00208	CcSEcCtD
Lurasidone—Skin disorder—Etoposide—sarcoma	0.0015	0.00207	CcSEcCtD
Lurasidone—HTR2A—tendon—sarcoma	0.0015	0.0104	CbGeAlD
Lurasidone—Hyperhidrosis—Etoposide—sarcoma	0.00149	0.00206	CcSEcCtD
Lurasidone—Abdominal pain upper—Doxorubicin—sarcoma	0.00149	0.00205	CcSEcCtD
Lurasidone—Orthostatic hypotension—Doxorubicin—sarcoma	0.00149	0.00205	CcSEcCtD
Lurasidone—Angina pectoris—Epirubicin—sarcoma	0.00148	0.00204	CcSEcCtD
Lurasidone—Breast disorder—Doxorubicin—sarcoma	0.00147	0.00203	CcSEcCtD
Lurasidone—Diarrhoea—Thiotepa—sarcoma	0.00147	0.00203	CcSEcCtD
Lurasidone—Abdominal pain—Mitoxantrone—sarcoma	0.00147	0.00202	CcSEcCtD
Lurasidone—Diarrhoea—Dactinomycin—sarcoma	0.00146	0.00201	CcSEcCtD
Lurasidone—ADRA2A—testis—sarcoma	0.00146	0.0101	CbGeAlD
Lurasidone—Nasopharyngitis—Doxorubicin—sarcoma	0.00146	0.00201	CcSEcCtD
Lurasidone—Hypotension—Etoposide—sarcoma	0.00144	0.00199	CcSEcCtD
Lurasidone—Gastritis—Doxorubicin—sarcoma	0.00144	0.00199	CcSEcCtD
Lurasidone—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.00144	0.00198	CcSEcCtD
Lurasidone—Dysuria—Epirubicin—sarcoma	0.00142	0.00196	CcSEcCtD
Lurasidone—Neutropenia—Epirubicin—sarcoma	0.00142	0.00196	CcSEcCtD
Lurasidone—Dizziness—Thiotepa—sarcoma	0.00142	0.00196	CcSEcCtD
Lurasidone—Influenza—Doxorubicin—sarcoma	0.00141	0.00194	CcSEcCtD
Lurasidone—Dysphagia—Doxorubicin—sarcoma	0.00141	0.00194	CcSEcCtD
Lurasidone—Eosinophilia—Doxorubicin—sarcoma	0.00139	0.00192	CcSEcCtD
Lurasidone—Weight increased—Epirubicin—sarcoma	0.00139	0.00191	CcSEcCtD
Lurasidone—Dyspnoea—Etoposide—sarcoma	0.00138	0.0019	CcSEcCtD
Lurasidone—Hyperglycaemia—Epirubicin—sarcoma	0.00137	0.00189	CcSEcCtD
Lurasidone—Somnolence—Etoposide—sarcoma	0.00137	0.00189	CcSEcCtD
Lurasidone—Angina pectoris—Doxorubicin—sarcoma	0.00137	0.00189	CcSEcCtD
Lurasidone—Asthenia—Vincristine—sarcoma	0.00137	0.00189	CcSEcCtD
Lurasidone—Vomiting—Thiotepa—sarcoma	0.00137	0.00188	CcSEcCtD
Lurasidone—Infestation NOS—Epirubicin—sarcoma	0.00136	0.00187	CcSEcCtD
Lurasidone—Infestation—Epirubicin—sarcoma	0.00136	0.00187	CcSEcCtD
Lurasidone—Vomiting—Dactinomycin—sarcoma	0.00136	0.00187	CcSEcCtD
Lurasidone—Rash—Thiotepa—sarcoma	0.00136	0.00187	CcSEcCtD
Lurasidone—Dermatitis—Thiotepa—sarcoma	0.00135	0.00187	CcSEcCtD
Lurasidone—Rash—Dactinomycin—sarcoma	0.00135	0.00185	CcSEcCtD
Lurasidone—Decreased appetite—Etoposide—sarcoma	0.00134	0.00185	CcSEcCtD
Lurasidone—Renal failure—Epirubicin—sarcoma	0.00133	0.00184	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Etoposide—sarcoma	0.00133	0.00184	CcSEcCtD
Lurasidone—Asthenia—Mitoxantrone—sarcoma	0.00133	0.00184	CcSEcCtD
Lurasidone—Fatigue—Etoposide—sarcoma	0.00133	0.00184	CcSEcCtD
Lurasidone—ADRA2C—lymph node—sarcoma	0.00133	0.00919	CbGeAlD
Lurasidone—Urinary tract infection—Epirubicin—sarcoma	0.00132	0.00182	CcSEcCtD
Lurasidone—Neutropenia—Doxorubicin—sarcoma	0.00132	0.00182	CcSEcCtD
Lurasidone—Dysuria—Doxorubicin—sarcoma	0.00132	0.00182	CcSEcCtD
Lurasidone—Diarrhoea—Vincristine—sarcoma	0.0013	0.0018	CcSEcCtD
Lurasidone—Hepatobiliary disease—Epirubicin—sarcoma	0.00128	0.00177	CcSEcCtD
Lurasidone—Weight increased—Doxorubicin—sarcoma	0.00128	0.00177	CcSEcCtD
Lurasidone—Nausea—Thiotepa—sarcoma	0.00128	0.00176	CcSEcCtD
Lurasidone—Hyperglycaemia—Doxorubicin—sarcoma	0.00127	0.00175	CcSEcCtD
Lurasidone—Diarrhoea—Mitoxantrone—sarcoma	0.00127	0.00175	CcSEcCtD
Lurasidone—Nausea—Dactinomycin—sarcoma	0.00127	0.00175	CcSEcCtD
Lurasidone—Agranulocytosis—Epirubicin—sarcoma	0.00127	0.00175	CcSEcCtD
Lurasidone—Gastrointestinal pain—Etoposide—sarcoma	0.00126	0.00174	CcSEcCtD
Lurasidone—Dizziness—Vincristine—sarcoma	0.00126	0.00174	CcSEcCtD
Lurasidone—Infestation NOS—Doxorubicin—sarcoma	0.00126	0.00173	CcSEcCtD
Lurasidone—Infestation—Doxorubicin—sarcoma	0.00126	0.00173	CcSEcCtD
Lurasidone—HTR2A—testis—sarcoma	0.00124	0.0086	CbGeAlD
Lurasidone—Bradycardia—Epirubicin—sarcoma	0.00124	0.00171	CcSEcCtD
Lurasidone—Renal failure—Doxorubicin—sarcoma	0.00123	0.0017	CcSEcCtD
Lurasidone—Abdominal pain—Etoposide—sarcoma	0.00122	0.00168	CcSEcCtD
Lurasidone—Urinary tract infection—Doxorubicin—sarcoma	0.00122	0.00168	CcSEcCtD
Lurasidone—Vomiting—Vincristine—sarcoma	0.00121	0.00167	CcSEcCtD
Lurasidone—Urinary tract disorder—Epirubicin—sarcoma	0.0012	0.00166	CcSEcCtD
Lurasidone—Rash—Vincristine—sarcoma	0.0012	0.00166	CcSEcCtD
Lurasidone—Dermatitis—Vincristine—sarcoma	0.0012	0.00166	CcSEcCtD
Lurasidone—Connective tissue disorder—Epirubicin—sarcoma	0.0012	0.00165	CcSEcCtD
Lurasidone—Urethral disorder—Epirubicin—sarcoma	0.00119	0.00165	CcSEcCtD
Lurasidone—Hepatobiliary disease—Doxorubicin—sarcoma	0.00119	0.00164	CcSEcCtD
Lurasidone—Vomiting—Mitoxantrone—sarcoma	0.00118	0.00163	CcSEcCtD
Lurasidone—HTR2A—liver—sarcoma	0.00117	0.00813	CbGeAlD
Lurasidone—Agranulocytosis—Doxorubicin—sarcoma	0.00117	0.00162	CcSEcCtD
Lurasidone—Rash—Mitoxantrone—sarcoma	0.00117	0.00161	CcSEcCtD
Lurasidone—Dermatitis—Mitoxantrone—sarcoma	0.00117	0.00161	CcSEcCtD
Lurasidone—Bradycardia—Doxorubicin—sarcoma	0.00115	0.00158	CcSEcCtD
Lurasidone—Eye disorder—Epirubicin—sarcoma	0.00114	0.00157	CcSEcCtD
Lurasidone—Nausea—Vincristine—sarcoma	0.00113	0.00156	CcSEcCtD
Lurasidone—Cardiac disorder—Epirubicin—sarcoma	0.00113	0.00156	CcSEcCtD
Lurasidone—Urinary tract disorder—Doxorubicin—sarcoma	0.00111	0.00153	CcSEcCtD
Lurasidone—Asthenia—Etoposide—sarcoma	0.00111	0.00153	CcSEcCtD
Lurasidone—Connective tissue disorder—Doxorubicin—sarcoma	0.00111	0.00153	CcSEcCtD
Lurasidone—Angiopathy—Epirubicin—sarcoma	0.00111	0.00152	CcSEcCtD
Lurasidone—Urethral disorder—Doxorubicin—sarcoma	0.00111	0.00152	CcSEcCtD
Lurasidone—Nausea—Mitoxantrone—sarcoma	0.0011	0.00152	CcSEcCtD
Lurasidone—Pruritus—Etoposide—sarcoma	0.00109	0.00151	CcSEcCtD
Lurasidone—Arrhythmia—Epirubicin—sarcoma	0.00109	0.0015	CcSEcCtD
Lurasidone—CYP3A4—liver—sarcoma	0.00109	0.00753	CbGeAlD
Lurasidone—Mental disorder—Epirubicin—sarcoma	0.00107	0.00147	CcSEcCtD
Lurasidone—Malnutrition—Epirubicin—sarcoma	0.00106	0.00146	CcSEcCtD
Lurasidone—ADRA2A—lymph node—sarcoma	0.00106	0.00733	CbGeAlD
Lurasidone—Diarrhoea—Etoposide—sarcoma	0.00106	0.00146	CcSEcCtD
Lurasidone—Eye disorder—Doxorubicin—sarcoma	0.00105	0.00145	CcSEcCtD
Lurasidone—Cardiac disorder—Doxorubicin—sarcoma	0.00105	0.00144	CcSEcCtD
Lurasidone—Flatulence—Epirubicin—sarcoma	0.00105	0.00144	CcSEcCtD
Lurasidone—Back pain—Epirubicin—sarcoma	0.00103	0.00141	CcSEcCtD
Lurasidone—Angiopathy—Doxorubicin—sarcoma	0.00102	0.00141	CcSEcCtD
Lurasidone—Dizziness—Etoposide—sarcoma	0.00102	0.00141	CcSEcCtD
Lurasidone—Muscle spasms—Epirubicin—sarcoma	0.00102	0.00141	CcSEcCtD
Lurasidone—Arrhythmia—Doxorubicin—sarcoma	0.00101	0.00139	CcSEcCtD
Lurasidone—Vision blurred—Epirubicin—sarcoma	0.001	0.00138	CcSEcCtD
Lurasidone—Mental disorder—Doxorubicin—sarcoma	0.000988	0.00136	CcSEcCtD
Lurasidone—Vomiting—Etoposide—sarcoma	0.000982	0.00135	CcSEcCtD
Lurasidone—Malnutrition—Doxorubicin—sarcoma	0.000982	0.00135	CcSEcCtD
Lurasidone—Anaemia—Epirubicin—sarcoma	0.000981	0.00135	CcSEcCtD
Lurasidone—Agitation—Epirubicin—sarcoma	0.000975	0.00134	CcSEcCtD
Lurasidone—Rash—Etoposide—sarcoma	0.000974	0.00134	CcSEcCtD
Lurasidone—Dermatitis—Etoposide—sarcoma	0.000973	0.00134	CcSEcCtD
Lurasidone—Flatulence—Doxorubicin—sarcoma	0.000967	0.00133	CcSEcCtD
Lurasidone—Malaise—Epirubicin—sarcoma	0.000957	0.00132	CcSEcCtD
Lurasidone—Vertigo—Epirubicin—sarcoma	0.000953	0.00131	CcSEcCtD
Lurasidone—Syncope—Epirubicin—sarcoma	0.000951	0.00131	CcSEcCtD
Lurasidone—Leukopenia—Epirubicin—sarcoma	0.00095	0.00131	CcSEcCtD
Lurasidone—Back pain—Doxorubicin—sarcoma	0.00095	0.00131	CcSEcCtD
Lurasidone—Muscle spasms—Doxorubicin—sarcoma	0.000944	0.0013	CcSEcCtD
Lurasidone—Loss of consciousness—Epirubicin—sarcoma	0.000932	0.00129	CcSEcCtD
Lurasidone—Vision blurred—Doxorubicin—sarcoma	0.000925	0.00127	CcSEcCtD
Lurasidone—Convulsion—Epirubicin—sarcoma	0.000919	0.00127	CcSEcCtD
Lurasidone—Nausea—Etoposide—sarcoma	0.000917	0.00126	CcSEcCtD
Lurasidone—Hypertension—Epirubicin—sarcoma	0.000916	0.00126	CcSEcCtD
Lurasidone—Anaemia—Doxorubicin—sarcoma	0.000907	0.00125	CcSEcCtD
Lurasidone—Myalgia—Epirubicin—sarcoma	0.000903	0.00124	CcSEcCtD
Lurasidone—Agitation—Doxorubicin—sarcoma	0.000902	0.00124	CcSEcCtD
Lurasidone—Anxiety—Epirubicin—sarcoma	0.0009	0.00124	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000897	0.00124	CcSEcCtD
Lurasidone—Malaise—Doxorubicin—sarcoma	0.000885	0.00122	CcSEcCtD
Lurasidone—Dry mouth—Epirubicin—sarcoma	0.000883	0.00122	CcSEcCtD
Lurasidone—Vertigo—Doxorubicin—sarcoma	0.000882	0.00122	CcSEcCtD
Lurasidone—Syncope—Doxorubicin—sarcoma	0.00088	0.00121	CcSEcCtD
Lurasidone—Leukopenia—Doxorubicin—sarcoma	0.000879	0.00121	CcSEcCtD
Lurasidone—Loss of consciousness—Doxorubicin—sarcoma	0.000863	0.00119	CcSEcCtD
Lurasidone—Infection—Epirubicin—sarcoma	0.00086	0.00119	CcSEcCtD
Lurasidone—Shock—Epirubicin—sarcoma	0.000852	0.00117	CcSEcCtD
Lurasidone—Convulsion—Doxorubicin—sarcoma	0.00085	0.00117	CcSEcCtD
Lurasidone—Nervous system disorder—Epirubicin—sarcoma	0.000849	0.00117	CcSEcCtD
Lurasidone—Hypertension—Doxorubicin—sarcoma	0.000847	0.00117	CcSEcCtD
Lurasidone—Tachycardia—Epirubicin—sarcoma	0.000845	0.00116	CcSEcCtD
Lurasidone—Skin disorder—Epirubicin—sarcoma	0.000841	0.00116	CcSEcCtD
Lurasidone—Hyperhidrosis—Epirubicin—sarcoma	0.000837	0.00115	CcSEcCtD
Lurasidone—Myalgia—Doxorubicin—sarcoma	0.000836	0.00115	CcSEcCtD
Lurasidone—Anxiety—Doxorubicin—sarcoma	0.000833	0.00115	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.00083	0.00114	CcSEcCtD
Lurasidone—Dry mouth—Doxorubicin—sarcoma	0.000817	0.00113	CcSEcCtD
Lurasidone—Hypotension—Epirubicin—sarcoma	0.000809	0.00111	CcSEcCtD
Lurasidone—Infection—Doxorubicin—sarcoma	0.000796	0.0011	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000789	0.00109	CcSEcCtD
Lurasidone—Shock—Doxorubicin—sarcoma	0.000788	0.00109	CcSEcCtD
Lurasidone—Nervous system disorder—Doxorubicin—sarcoma	0.000786	0.00108	CcSEcCtD
Lurasidone—Insomnia—Epirubicin—sarcoma	0.000783	0.00108	CcSEcCtD
Lurasidone—Tachycardia—Doxorubicin—sarcoma	0.000782	0.00108	CcSEcCtD
Lurasidone—Skin disorder—Doxorubicin—sarcoma	0.000778	0.00107	CcSEcCtD
Lurasidone—Hyperhidrosis—Doxorubicin—sarcoma	0.000774	0.00107	CcSEcCtD
Lurasidone—Dyspnoea—Epirubicin—sarcoma	0.000772	0.00106	CcSEcCtD
Lurasidone—Somnolence—Epirubicin—sarcoma	0.00077	0.00106	CcSEcCtD
Lurasidone—Dyspepsia—Epirubicin—sarcoma	0.000762	0.00105	CcSEcCtD
Lurasidone—Decreased appetite—Epirubicin—sarcoma	0.000753	0.00104	CcSEcCtD
Lurasidone—Hypotension—Doxorubicin—sarcoma	0.000749	0.00103	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Epirubicin—sarcoma	0.000747	0.00103	CcSEcCtD
Lurasidone—Fatigue—Epirubicin—sarcoma	0.000746	0.00103	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.00073	0.00101	CcSEcCtD
Lurasidone—Insomnia—Doxorubicin—sarcoma	0.000725	0.000999	CcSEcCtD
Lurasidone—Dyspnoea—Doxorubicin—sarcoma	0.000714	0.000984	CcSEcCtD
Lurasidone—Somnolence—Doxorubicin—sarcoma	0.000712	0.000982	CcSEcCtD
Lurasidone—Gastrointestinal pain—Epirubicin—sarcoma	0.000708	0.000976	CcSEcCtD
Lurasidone—Dyspepsia—Doxorubicin—sarcoma	0.000705	0.000972	CcSEcCtD
Lurasidone—Decreased appetite—Doxorubicin—sarcoma	0.000696	0.00096	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000692	0.000953	CcSEcCtD
Lurasidone—Fatigue—Doxorubicin—sarcoma	0.000691	0.000952	CcSEcCtD
Lurasidone—Abdominal pain—Epirubicin—sarcoma	0.000684	0.000943	CcSEcCtD
Lurasidone—Gastrointestinal pain—Doxorubicin—sarcoma	0.000655	0.000903	CcSEcCtD
Lurasidone—Abdominal pain—Doxorubicin—sarcoma	0.000633	0.000873	CcSEcCtD
Lurasidone—Asthenia—Epirubicin—sarcoma	0.000621	0.000856	CcSEcCtD
Lurasidone—Pruritus—Epirubicin—sarcoma	0.000613	0.000844	CcSEcCtD
Lurasidone—Diarrhoea—Epirubicin—sarcoma	0.000592	0.000816	CcSEcCtD
Lurasidone—Asthenia—Doxorubicin—sarcoma	0.000575	0.000792	CcSEcCtD
Lurasidone—Dizziness—Epirubicin—sarcoma	0.000573	0.000789	CcSEcCtD
Lurasidone—Pruritus—Doxorubicin—sarcoma	0.000567	0.000781	CcSEcCtD
Lurasidone—Vomiting—Epirubicin—sarcoma	0.000551	0.000759	CcSEcCtD
Lurasidone—Diarrhoea—Doxorubicin—sarcoma	0.000548	0.000755	CcSEcCtD
Lurasidone—Rash—Epirubicin—sarcoma	0.000546	0.000752	CcSEcCtD
Lurasidone—Dermatitis—Epirubicin—sarcoma	0.000545	0.000752	CcSEcCtD
Lurasidone—Dizziness—Doxorubicin—sarcoma	0.00053	0.00073	CcSEcCtD
Lurasidone—Nausea—Epirubicin—sarcoma	0.000514	0.000709	CcSEcCtD
Lurasidone—Vomiting—Doxorubicin—sarcoma	0.000509	0.000702	CcSEcCtD
Lurasidone—Rash—Doxorubicin—sarcoma	0.000505	0.000696	CcSEcCtD
Lurasidone—Dermatitis—Doxorubicin—sarcoma	0.000505	0.000695	CcSEcCtD
Lurasidone—Nausea—Doxorubicin—sarcoma	0.000476	0.000656	CcSEcCtD
